Skip to main content

Chlorpheniramine / dextromethorphan / methscopolamine Pregnancy and Breastfeeding Warnings

Chlorpheniramine / dextromethorphan / methscopolamine is also known as: Extendryl DM

Chlorpheniramine / dextromethorphan / methscopolamine Pregnancy Warnings

Chlorpheniramine/DM/methscopolamine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Chlorpheniramine/dextromethorphan/phenylephrine is only recommended for use during pregnancy when benefit outweighs risk.

See references

Chlorpheniramine / dextromethorphan / methscopolamine Breastfeeding Warnings

There are no data on the excretion of chlorpheniramine/DM/methscopolamine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Extendryl DM (chlorpheniramine/DM/methscopolamine)." Apothecon Inc (2022):

References for breastfeeding information

  1. "Product Information. Extendryl DM (chlorpheniramine/DM/methscopolamine)." Apothecon Inc (2022):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.